Abstract
Microarrays: Technologies, Applications, Markets evaluates the
competitive picture, growth trends, and deal-making activities in this dynamic
and rapidly-growing market.
The market for DNA microarrays has grown significantly since its inception in
the mid-1990s. New players have entered the market in recent years, driving
improvements in product quality and a search for new market opportunities. The
prospect of participation in the $20 billion in vitro diagnostics industry
serves as a further incentive to current and emerging industry players, creating
a fiercely competitive environment.
Microarrays: Technologies, Applications, Markets provides insightful
and innovative business strategies and market acumen for companies striving to
capitalize on the many evolving opportunities in this profitable but challenging
business sector. The following critical areas are covered in detail to present a
complete competitive view of the microarray market:
- Current and emerging applications of DNA microarray technologies are
reviewed and assessed.
- Growth trends are analyzed for genome-wide arrays for both major and less
prevalent organisms, medium-density special-purpose arrays, custom arrays,
and high-throughput entries. Potential market sizes versus predicted growth
rates are considered.
- The DNA microarray market and the competitive environment are analyzed,
including expanded company profiles and SWOT analysis of the market leaders
and their technologies. The profiles examine each companys alliances,
intellectual property portfolio, and advantages over competing technologies.
- In addition to the first-tier players, the report evaluates the
technologies and strategies of new entrants to the market who are developing
new tools to challenge and extend the status quo.
- The untapped market potential of high-throughput array technology is
discussed. As pharmaceutical and biotechnology companies increasingly
identify biomarkers, the emphasis will increasingly fall on high-throughput
arrays for a number of activities downstream from discovery, with emphasis
on toxicogenomics for drug safety prediction.
View Cart
